SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-027832
Filing Date
2019-05-08
Accepted
2019-05-08 16:34:47
Documents
2
Period of Report
2019-04-26
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-9651_18k.htm 8-K 30349
2 EX-3.1 a19-9651_1ex3d1.htm EX-3.1 107618
  Complete submission text file 0001104659-19-027832.txt   139136
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 19807169
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1